Clinical Trial Update: Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study） [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating multi-intravenous infusion of umbilical cord mesenchymal stem cells in heart failure with reduced ejection fraction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shanghai East Hospital | Conditions: Heart Failure, Systolic | Phase 1, Phase 2 | Status: COMPLETED